Effects of lifestyle intervention on IGF-1, IGFBP-3, and insulin resistance in children with obesity with or without metabolic-associated fatty liver disease
机构:[1]Department of Hepatology and Gastroenterologyand Department of Clinical Medicine, Aarhus UniversityHospital, Aarhus, Denmark[2]Department of Hepatology, Shenzhen Traditional ChineseMedicine Hospital, Shenzhen, Guangdong Province, China深圳市康宁医院深圳医学信息中心[3]Department of Gastroenterology and Hepatology, AalborgUniversity Hospital, Aalborg, Denmark[4]Department of Pediatrics and Adolescent Medicine, AarhusUniversity Hospital, Aalborg, Denmark[5]Steno Diabetes Center Aarhus, Aarhus University Hospital,Aarhus, Denmark[6]Department of Radiology, Aarhus University Hospital,Aarhus, Denmark[7]Department of Clinical Medicine, Health, Aarhus University,Aarhus, Denmark[8]Department of Endocrinology, Odense University Hospital,Odense, Denmark[9]Department of Clinical Research, Faculty of Health,University of Southern Denmark, Odense, Denmark
“Helsefonden, Denmark” and the Sanming
Project of Medicine in Shenzhen (No. SZSM201612074) and Science and Technology Program of Shenzhen (No. JCYJ20190812164211151) of
China.
第一作者机构:[1]Department of Hepatology and Gastroenterologyand Department of Clinical Medicine, Aarhus UniversityHospital, Aarhus, Denmark
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
David Haldrup,Chunshan Wei,Peter Holland‑Fischer,et al.Effects of lifestyle intervention on IGF-1, IGFBP-3, and insulin resistance in children with obesity with or without metabolic-associated fatty liver disease[J].EUROPEAN JOURNAL OF PEDIATRICS.2023,182(2):855-865.doi:10.1007/s00431-022-04731-1.
APA:
David Haldrup,Chunshan Wei,Peter Holland‑Fischer,Kurt Kristensen,Søren Rittig...&Jan Frystyk.(2023).Effects of lifestyle intervention on IGF-1, IGFBP-3, and insulin resistance in children with obesity with or without metabolic-associated fatty liver disease.EUROPEAN JOURNAL OF PEDIATRICS,182,(2)
MLA:
David Haldrup,et al."Effects of lifestyle intervention on IGF-1, IGFBP-3, and insulin resistance in children with obesity with or without metabolic-associated fatty liver disease".EUROPEAN JOURNAL OF PEDIATRICS 182..2(2023):855-865